PARG inhibition induces nuclear aggregation of PARylated PARP1
Structure · 2024-11 · 32 (11) · 2083-2093.e5
DOI: 10.1016/j.str.2024.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2024-11. Verfasst von Sateja Paradkar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University Scho…. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Glycoside Hydrolases, Cell Nucleus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Cancer Institute, National Institutes of Health, National Brain Tumor Society.
Abstract (Originalsprache)
Poly (ADP-ribose) glycohydrolase (PARG) inhibitors are currently under clinical development for the treatment of DNA repair-deficient cancers; however, their precise mechanism of action is still unclear. Here, we report that PARG inhibition leads to excessive PARylated poly (ADP-ribose) polymerase 1 (PARP1) reducing the ability of PARP1 to properly localize to sites of DNA damage. Strikingly, the mis-localized PARP1 accumulates as aggregates throughout the nucleus. Abrogation of the catalytic activity of PARP1 prevents aggregate formation, indicating that PAR chains play a key role in this process. Finally, we find that PARP1 nuclear aggregates were highly persistent and were associated with cleaved cytoplasmic PARP1, ultimately leading to cell death. Overall, our data uncover an unexpected mechanism of PARG inhibitor cytotoxicity, which will shed light on the use of these drugs as anti-cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510-8034, USA. Electronic address: sat…
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA.
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510-8034, USA.
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510-8034, USA. Electronic address: ran…
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8034, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510-8034, USA. Electronic address: rya…
Förderung
- National Cancer Institute
- National Institutes of Health
- National Brain Tumor Society
Zitieren
APA
Paradkar, S., Purcell, J., Cui, A., Friedman, S., Noronha, K. J., Murray, M. A., Sundaram, R. K., Bindra, R. S., & Jensen, R. B. (2024). PARG inhibition induces nuclear aggregation of PARylated PARP1. Structure, 32(11), 2083-2093.e5. https://doi.org/10.1016/j.str.2024.09.006
Vancouver
Paradkar S, Purcell J, Cui A, Friedman S, Noronha KJ, Murray MA, et al. PARG inhibition induces nuclear aggregation of PARylated PARP1. Structure. 2024;32(11):2083-2093.e5. doi:10.1016/j.str.2024.09.006
BibTeX
@article{Paradkar2024,
author = {Paradkar, Sateja and Purcell, Julia and Cui, Annie and Friedman, Sam and Noronha, Katelyn J and Murray, Matthew A and Sundaram, Ranjini K and Bindra, Ranjit S and Jensen, Ryan B},
title = {PARG inhibition induces nuclear aggregation of PARylated PARP1},
journal = {Structure},
year = {2024},
volume = {32},
number = {11},
pages = {2083--2093.e5},
doi = {10.1016/j.str.2024.09.006}
}
EUVIMED